The other article that I found mentioned dosing as a consideration on these cases. What is the recommended dose for Marine vs Reduce-It? If they are different and generic sales are skewed toward the Reduce-It doses, this may help prove Amarin's case.
I just found some of the earlier discussion about this from yesterday. Can information be obtained on the type of doctor who is prescribing Vascepa? If it is mostly cardiologists or similar (Reduce-It) as opposed to gastroenterologists (Marine)-that also would help any infringement case.